The intermediate filament peripherin is expressed in cutaneous melanocytic lesions

被引:30
|
作者
Prieto, VG [1 ]
McNutt, NS [1 ]
Lugo, J [1 ]
Reed, JA [1 ]
机构
[1] NEW YORK HOSP,CORNELL MED CTR,DEPT DERMATOL,NEW YORK,NY 10021
关键词
D O I
10.1111/j.1600-0560.1997.tb01568.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Peripherin is an intermediate filament involved in growth and development of the peripheral nervous system and is localized to neurons, some other cells derived from neural tube and neuraI crest, and some neuroendocrine cells (e.g. beta cells of islets of Langerhans). Peripherin also has been demonstrated in neuroblastomas and cutaneous neuroendocrine (Merkel cell) carcinomas. The expression of peripherin by other cells derived from the neural crest is unknown. We evaluated by immunohistochemistry 74 cutaneous melanocytic lesions including primary invasive malignant melanoma (IMM), melanoma in situ (MIS), atypical nevus (nevus with architectural disorder and cytologic atypia of melanocytes) (AN), spindle and epithelioid cell nevus (Spitz nevus) (SN), blue nevus (BN), and common intradermal benign melanocytic nevus (BMN) for expression of peripherin. Peripherin was detected in a cytoplasmic distribution within tumor cells in 14/14 IMM and 8/10 MIS. For IMM, peripherin localized to both the intraepidermal and invasive dermal components. Peripherin was detected in 10/10 AN and 9/9 SN, being localized to the intraepidermal component and, focally, to the superficial dermal component of the lesions. The dendritic nevus cells in 15/15 BN also expressed peripherin. For most of the BMN, expression of peripherin was absent or limited to rare, scattered cells in the superficial portion of the lesions. Melanocytes in adjacent normal skin were not labeled in any of the lesions studied. These results indicate that expression of peripherin is common in both benign and malignant melanocytic lesions, but not in normal resting adult melanocytes. Among benign lesions, expression of peripherin in the dermal component is rare except in the dendritic cells of BN. These findings provide evidence that the expression of peripherin, a marker of neuronal differentiation, is maintained by IMM, MIS, and BN, but is lost in the normal maturational sequence of the dermal component of other melanocytic lesions.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 50 条
  • [41] The intermediate filament protein peripherin is a marker for cerebellar climbing fibres (vol 27, pg 2, 1998)
    Errante, L
    Tang, D
    Gardon, M
    Sekerkova, G
    Mugnaini, E
    Shaw, G
    JOURNAL OF NEUROCYTOLOGY, 1998, 27 (04): : 281 - 288
  • [42] Type III intermediate filament peripherin inhibits neuritogenesis in type II spiral ganglion neurons in vitro
    Barclay, Meagan
    Julien, Jean-Pierre
    Ryan, Allen F.
    Housley, Gary D.
    NEUROSCIENCE LETTERS, 2010, 478 (02) : 51 - 55
  • [43] EXPRESSION OF THE NEURAL INTERMEDIATE FILAMENT PROTEINS PERIPHERIN AND NEUROFILAMENT-66/ALPHA-INTERNEXIN IN NEUROBLASTOMA
    FOLEY, J
    WITTE, D
    CHIU, FC
    PARYSEK, LM
    LABORATORY INVESTIGATION, 1994, 71 (02) : 193 - 199
  • [44] Tyrosine Nitration is a Novel Post-translational Modification Occurring on the Neural Intermediate Filament Protein Peripherin
    Gabriella Tedeschi
    Graziella Cappelletti
    Simona Nonnis
    Francesca Taverna
    Armando Negri
    Cristina Ronchi
    Severino Ronchi
    Neurochemical Research, 2007, 32 : 433 - 441
  • [45] PRAME immunoexpression in 275 cutaneous melanocytic lesions: a single institutional experience
    Cazzato, G.
    Colagrande, A.
    Mangialardi, K.
    Ingravallo, G.
    Resta, L.
    HISTOPATHOLOGY, 2022, 81 : 43 - 43
  • [46] Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions
    Piepkorn, Michael W.
    Longton, Gary M.
    Reisch, Lisa M.
    Elder, David E.
    Pepe, Margaret S.
    Kerr, Kathleen F.
    Tosteson, Anna N. A.
    Nelson, Heidi D.
    Knezevich, Stevan
    Radick, Andrea
    Shucard, Hannah
    Onega, Tracy
    Carney, Patricia A.
    Elmore, Joann G.
    Barnhill, Raymond L.
    JAMA NETWORK OPEN, 2019, 2 (10)
  • [47] Immunohistochemical study of CD117 in various cutaneous melanocytic lesions
    Radu, Antonia
    Bejenaru, Cornelia
    Tolea, Ion
    Maranduca, Minela Aida
    Branisteanu, Daniel Constantin
    Bejenaru, Ludovic Everard
    Petrariu, Florin Dumitru
    Stoleriu, Gabriela
    Branisteanu, Daciana Elena
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (01)
  • [48] PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience
    Cazzato, Gerardo
    Cascardi, Eliano
    Colagrande, Anna
    Belsito, Vincenzo
    Lospalluti, Lucia
    Foti, Caterina
    Arezzo, Francesca
    Dellino, Miriam
    Casatta, Nadia
    Lupo, Carmelo
    Buongiorno, Luigi
    Stellacci, Alessandra
    Marrone, Maricla
    Ingravallo, Giuseppe
    Maiorano, Eugenio
    Resta, Leonardo
    DIAGNOSTICS, 2022, 12 (09)
  • [49] Expression of human sperm protein 17 in melanophages of cutaneous melanocytic lesions
    Franceschini, B
    Grizzi, F
    Colombo, P
    Soda, G
    Bumm, K
    Hermonat, PL
    Monti, M
    Dioguardi, N
    Chiriva-Internati, M
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (04) : 780 - 782
  • [50] Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions
    van Dijk, M. C. R. F.
    Aben, K. K. H.
    van Hees, F.
    Klaasen, A.
    Blokx, W. A. M.
    Kiemeney, L. A. L. M.
    Ruiter, D. J.
    HISTOPATHOLOGY, 2008, 52 (02) : 139 - 146